Insulin Resistance, Inflammation, and Blood Pressure Determine Vascular Dysfunction in CKD

American Journal of Kidney Diseases

Volumn 48, Issue 6, 2006, Pages 926-934

  Dogra, Gursharan ^a   Irish, Ashley ^a   Chan, Dick ^a   Watts, Gerald ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

arterial compliance; Chronic kidney disease (CKD); dyslipidemia; endothelial function; inflammation; insulin resistance

Indexed keywords

CALCIUM; GLUCOSE; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 6; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATE; TRIACYLGLYCEROL;

ADULT; ARTERY COMPLIANCE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL INJURY; BRACHIAL ARTERY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHOSPHATE BLOOD LEVEL; PULSE PRESSURE; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTERIES; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NITROGLYCERIN; OXIDATIVE STRESS; PULSE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASODILATOR AGENTS;

EID: 33845410717     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.08.008     Document Type: Article

References (53)

1. Baigent C., Burbury K., and Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 356 (2000) 147-152
2. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
3. Attman P.O., Samuelsson O., and Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis 21 (1993) 573-592
4. Lowrie E.G., and Lew N.L. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15 (1990) 458-482
5. Zoccali C. Cardiovascular risk in uraemic patients-Is it fully explained by classical risk factors?. Nephrol Dial Transplant 15 (2000) 454-457
6. Locatelli F., Canaud B., Eckardt K.U., Stenvinkel P., Wanner C., and Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 18 (2003) 1272-1280
7. Yeun J.Y., and Kaysen G.A. C-Reactive protein, oxidative stress, homocysteine, and troponin as inflammatory and metabolic predictors of atherosclerosis in ESRD. Curr Opin Nephrol Hypertens 9 (2000) 621-630
8. Stenvinkel P., Barany P., Heimburger O., Pecoits-Filho R., and Lindholm B. Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?. Kidney Int Suppl 80 (2002) S103-S108
9. Blacher J., Guerin A.P., Pannier B., Marchais S.J., and London G.M. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38 (2001) 938-942
10. DeFronzo R.A., Alvestrand A., Smith D., Hendler R., Hendler E., and Wahren J. Insulin resistance in uremia. J Clin Invest 67 (1981) 563-568
11. Schmitz O., Alberti K.G., Christensen N.J., et al. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 34 (1985) 465-473
12. Fliser D., Pacini G., Engelleiter R., et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53 (1998) 1343-1347
13. Shinohara K., Shoji T., Emoto M., et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13 (2002) 1894-1900
14. Rubanyi G.M. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 suppl 4 (1993) S1-S14
15. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
16. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 (1995) 1235-1241
17. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 129 (1997) 111-118
18. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
19. Neunteufl T., Heher S., Katzenschlager R., et al. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 86 (2000) 207-210
20. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
21. Grey E., Bratteli C., Glasser S.P., et al. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 16 (2003) 265-269
22. Annuk M., Lind L., Linde T., and Fellstrom B. Impaired endothelium-dependent vasodilatation in renal failure in humans. Nephrol Dial Transplant 16 (2001) 302-306
23. Pannier B., Guerin A.P., Marchais S.J., Metivier F., Safar M.E., and London G.M. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 57 (2000) 1091-1099
24. van Guldener C., Lambert J., Janssen M.J., Donker A.J., and Stehouwer C.D. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 12 suppl 2 (1997) S14-S18
25. London G.M., Guerin A.P., Marchais S.J., et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50 (1996) 600-608
26. London G.M. Arterial function in renal failure. Nephrol Dial Transplant 13 suppl 4 (1998) S12-S15
27. Blacher J., Safar M.E., Guerin A.P., Pannier B., Marchais S.J., and London G.M. Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int 63 (2003) 1852-1860
28. London G.M., Blacher J., Pannier B., Guerin A.P., Marchais S.J., and Safar M.E. Arterial wave reflections and survival in end-stage renal failure. Hypertension 38 (2001) 434-438
29. Woodman R.J., and Watts G.F. Measurement and application of arterial stiffness in clinical research: Focus on new methodologies and diabetes mellitus. Med Sci Monit 9 (2003) RA81-RA89
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis Model Assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
31. Woodman R.J., Playford D.A., Watts G.F., et al. Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol 91 (2001) 929-937
32. Shinohara K., Shoji T., Tsujimoto Y., et al. Arterial stiffness in predialysis patients with uremia. Kidney Int 65 (2004) 936-943
33. Liu Y., Coresh J., Eustace J.A., et al. Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291 (2004) 451-459
34. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005) 238-248
35. Fathi R., Isbel N., Short L., Haluska B., Johnson D., and Marwick T.H. The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. Am J Kidney Dis 43 (2004) 45-52
36. Isbel N.M., Haluska B., Johnson D.W., Beller E., Hawley C., and Marwick T.H. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Am Heart J 151 (2006) 745-753
37. Rakhit D.J., Marwick T.H., Armstrong K.A., Johnson D.W., Leano R., and Isbel N.M. Effect of aggressive risk factor modification on cardiac events and myocardial ischemia in patients with chronic kidney disease. Heart Online 92 (2006) 1402-1408
38. Passauer J., Bussemaker E., Range U., Plug M., and Gross P. Evidence in vivo showing increase of baseline nitric oxide generation and impairment of endothelium-dependent vasodilation in normotensive patients on chronic hemodialysis. J Am Soc Nephrol 11 (2000) 1726-1734
39. Joannides R., Bakkali E.H., Le Roy F., et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 12 (1997) 2623-2628
40. Nakanishi T., Ishigami Y., Otaki Y., et al. Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure. Nephron 92 (2002) 529-535
41. Zenere B.M., Arcaro G., Saggiani F., Rossi L., Muggeo M., and Lechi A. Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 18 (1995) 975-982
42. Lekakis J., Papamichael C., Anastasiou H., et al. Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc Res 34 (1997) 164-168
43. Adams M.R., Robinson J., McCredie R., et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 32 (1998) 123-127
44. van Guldener C., Janssen M.J., Lambert J., Steyn M., Donker A.J., and Stehouwer C.D. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 13 (1998) 1782-1786
45. Morris S.T., McMurray J.J., Rodger R.S., and Jardine A.G. Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 15 (2000) 1194-1200
46. Wang D., Iversen J., and Strandgaard S. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 11 (2000) 1371-1376
47. Kari J.A., Donald A.E., Vallance D.T., et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52 (1997) 468-472
48. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100 (1997) 2153-2157
49. Yilmaz M.I., Saglam M., Caglar K., et al. The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47 (2006) 42-50
50. Taddei S., Virdis A., Ghiadoni L., and Salvetti A. The role of endothelium in human hypertension. Curr Opin Nephrol Hypertens 7 (1998) 203-209
51. Playford D.A., and Watts G.F. Endothelial dysfunction, insulin resistance and diabetes: Exploring the web of causality. Aust N Z J Med 29 (1999) 523-534
52. Tozawa M., Iseki K., Iseki C., and Takishita S. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61 (2002) 717-726
53. Ketteler M., Gross M.L., and Ritz E. Calcification and cardiovascular problems in renal failure. Kidney Int Suppl 94 (2005) S120-S127